Search research articles
Contact Us
Filters
Showing results (121-130 of 186) with videos related to
Page
of 19
Sort By:
Cerebral Cortex (New York, N.Y. : 1991)
|
July 6, 2014
Disrupted Intrinsic Networks Link Amyloid-β Pathology and Impaired Cognition in Prodromal Alzheimer's Disease
Kathrin Koch, Nicholas E Myers, Jens Göttler, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
August 9, 2015
Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease
Panagiotis Alexopoulos, Jennifer Roesler, Nathalie Thierjung, et al.
International Journal of Methods in Psychiatric Research
|
March 15, 2022
Cognitive impairment and microvascular function in end-stage renal disease
Susanne Angermann, Roman Günthner, Henner Hanssen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Marwan N Sabbagh, Audrey Gabelle, Timo Grimmer, et al.
International Psychogeriatrics
|
October 2, 2015
Trends of patient referral to a memory clinic and towards earlier diagnosis from 1985-2009
Timo Grimmer, Stephanie Beringer, Victoria Kehl, et al.
Journal of Alzheimer'S Disease : JAD
|
March 26, 2019
Plasma Levels of Soluble AβPPβ as a Biomarker for Alzheimer's Disease with Dementia
Panagiotis Alexopoulos, Nathalie Thierjung, Polychronis Economou, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Audrey Gabelle, Marwan N Sabbagh, Timo Grimmer, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 7, 2021
Intepirdine as adjunctive therapy to donepezil for mild-to-moderate Alzheimer's disease: A randomized, placebo-controlled, phase 3 clinical trial (MINDSET)
Frederick M Lang, Yi Mo, Marwan Sabbagh, et al.
Clinical Science (London, England : 1979)
|
May 13, 2017
Pulse wave velocity is associated with cognitive impairment in hemodialysis patients
Susanne Angermann, Marcus Baumann, Siegfried Wassertheurer, et al.
Alzheimer'S Research & Therapy
|
October 13, 2018
Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study
Philip Scheltens, Merja Hallikainen, Timo Grimmer, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 186) with videos related to
Sort By:
Page
of 19
Cerebral Cortex (New York, N.Y. : 1991)
|
July 6, 2014
Disrupted Intrinsic Networks Link Amyloid-β Pathology and Impaired Cognition in Prodromal Alzheimer's Disease
Kathrin Koch, Nicholas E Myers, Jens Göttler, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
August 9, 2015
Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease
Panagiotis Alexopoulos, Jennifer Roesler, Nathalie Thierjung, et al.
International Journal of Methods in Psychiatric Research
|
March 15, 2022
Cognitive impairment and microvascular function in end-stage renal disease
Susanne Angermann, Roman Günthner, Henner Hanssen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Marwan N Sabbagh, Audrey Gabelle, Timo Grimmer, et al.
International Psychogeriatrics
|
October 2, 2015
Trends of patient referral to a memory clinic and towards earlier diagnosis from 1985-2009
Timo Grimmer, Stephanie Beringer, Victoria Kehl, et al.
Journal of Alzheimer'S Disease : JAD
|
March 26, 2019
Plasma Levels of Soluble AβPPβ as a Biomarker for Alzheimer's Disease with Dementia
Panagiotis Alexopoulos, Nathalie Thierjung, Polychronis Economou, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Audrey Gabelle, Marwan N Sabbagh, Timo Grimmer, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 7, 2021
Intepirdine as adjunctive therapy to donepezil for mild-to-moderate Alzheimer's disease: A randomized, placebo-controlled, phase 3 clinical trial (MINDSET)
Frederick M Lang, Yi Mo, Marwan Sabbagh, et al.
Clinical Science (London, England : 1979)
|
May 13, 2017
Pulse wave velocity is associated with cognitive impairment in hemodialysis patients
Susanne Angermann, Marcus Baumann, Siegfried Wassertheurer, et al.
Alzheimer'S Research & Therapy
|
October 13, 2018
Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study
Philip Scheltens, Merja Hallikainen, Timo Grimmer, et al.
Page
of 19